IRF4 and BATF are critical for CD8+ T-cell function following infection with LCMV

Cell Death and Differentiation

Volumn 21, Issue 7, 2014, Pages 1050-1060

  Grusdat, M ^a   McIlwain, D R ^a   Xu, H C ^a,b   Pozdeev, V I ^a   Knievel, J ^a   Crome, S Q ^c   Robert Tissot, C ^c   Dress, R J ^a   Pandyra, A A ^b   Speiser, D E ^c,d   Lang, E ^a   Maney, S K ^a   Elford, A R ^c   Hamilton, S R ^c   Scheu, S ^a   Pfeffer, K ^a   Bode, J ^a   Mittrucker H W ^e   Lohoff, M ^f   Huber, M ^f   Haussinger D ^a   Ohashi, P S ^c   Mak, T W ^c   Lang, K S ^b   Lang, P A ^a   more..

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d Clinical Tumor Biology and Immunotherapy Group Department of Oncology Ludwig Center for Cancer Research   (Switzerland)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^f PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

BATF; hepatitis; immunopathology; IRF4; LCMV

Indexed keywords

B CELL ACTIVATING FACTOR; GAMMA INTERFERON; INTERFERON REGULATORY FACTOR 4; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; BATF PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HEPATITIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; INFECTION CONTROL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; APOPTOSIS; C57BL MOUSE; CELL CULTURE; CYTOTOXICITY; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; PHYSIOLOGY; VIROLOGY;

ANIMALS; APOPTOSIS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; IMMUNOLOGIC MEMORY; INTERFERON REGULATORY FACTORS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84902277611     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.19     Document Type: Article

References (35)

1. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005; 5: 215-229.
2. Walker BD, Yu XG. Unravelling the mechanisms of durable control of HIV-1. Nat Rev Immunol 2013; 13: 487-498.
3. Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997; 275: 540-543.
4. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, Kock S et al. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci USA 2002; 99: 11808-11812.
5. Rengarajan J, Mowen KA, McBride KD, Smith ED, Singh H, Glimcher LH. Interferon regulatory factor 4 (IRF4) interacts with NFATc2 to modulate interleukin 4 gene expression. J Exp Med 2002; 195: 1003-1012.
6. Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu TT et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses. Nature 2009; 458: 351-356.
7. Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N et al. Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 2010; 33: 192-202.
8. Brustle A, Heink S, Huber M, Rosenplanter C, Stadelmann C, Yu P et al. The development of inflammatory T(H)-17 cells requires interferon-regulatory factor 4. Nat Immunol 2007; 8: 958-966.
9. Nayar R, Enos M, Prince A, Shin H, Hemmers S, Jiang JK et al. TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation. Proc Natl Acad Sci USA 2012; 109: E2794-E2802.
10. Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, Visekruna A et al. IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest 2013; 123: 247-260.
11. Raczkowski F, Ritter J, Heesch K, Schumacher V, Guralnik A, Hocker L et al. The transcription factor interferon regulatory factor 4 is required for the generation of protective effector CD8+ T cells. Proc Natl Acad Sci USA 2013; 110: 15019-15024.
12. Man K, Miasari M, Shi W, Xin A, Henstridge DC, Preston S et al. The transcription factor IRF4 is essential for TCR affinity-mediated metabolic programming and clonal expansion of T cells. Nat Immunol 2013; 14: 1155-1165.
13. Yao S, Buzo BF, Pham D, Jiang L, Taparowsky EJ, Kaplan MH et al. Interferon regulatory factor 4 sustains CD8(+) T cell expansion and effector differentiation. Immunity 2013; 39: 833-845.
14. Glasmacher E, Agrawal S, Chang AB, Murphy TL, Zeng W, Vander Lugt B et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 2012; 338: 975-980.
15. Li P, Spolski R, Liao W, Wang L, Murphy TL, Murphy KM et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 2012; 490: 543-546.
16. Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli F et al. A validated regulatory network for Th17 cell specification. Cell 2012; 151: 289-303.
17. Murphy TL, Tussiwand R, Murphy KM. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks. Nat Rev Immunol 2013; 13: 499-509.
18. Kuroda S, Yamazaki M, Abe M, Sakimura K, Takayanagi H, Iwai Y. Basic leucine zipper transcription factor, ATF-like (BATF) regulates epigenetically and energetically effector CD8 T-cell differentiation via Sirt1 expression. Proc Natl Acad Sci USA 2011; 108: 14885-14889.
19. Zinkernagel RM, Haenseler E, Leist T, Cerny A, Hengartner H, Althage A. T cell-mediated hepatitis in mice infected with lymphocytic choriomeningitis virus. Liver cell destruction by H-2 class I-restricted virus-specific cytotoxic T cells as a physiological correlate of the 51Cr-release assay? J Exp Med 1986; 164: 1075-1092.
20. Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M et al. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med 2008; 14: 756-761.
21. Pircher H, Burki K, Lang R, Hengartner H, Zinkernagel RM. Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen. Nature 1989; 342: 559-561.
22. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1- deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869-877.
23. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439: 682-687.
24. Hany M, Oehen S, Schulz M, Hengartner H, Mackett M, Bishop DH et al. Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein. Eur J Immunol 1989; 19: 417-424.
25. Schraml BU, Hildner K, Ise W, Lee WL, Smith WA, Solomon B et al. The AP-1 transcription factor Batf controls T(H)17 differentiation. Nature 2009; 460: 405-409.
26. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013; 5: a008656.
27. He MX, He YW. A role for c-FLIP(L) in the regulation of apoptosis, autophagy, and necroptosis in T lymphocytes. Cell Death Differ 2013; 20: 188-197.
28. Tripathi P, Koss B, Opferman JT, Hildeman DA. Mcl-1 antagonizes Bax/Bak to promote effector CD4(+) and CD8(+) T-cell responses. Cell Death Differ 2013; 20: 998-1007.
29. Wherry EJ. T cell exhaustion. Nat Immunol 2011; 12: 492-499.
30. Quigley M, Pereyra F, Nilsson B, Porichis F, Fonseca C, Eichbaum Q et al. Transcriptional analysis of HIV-specific CD8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 2010; 16: 1147-1151.
31. McIlwain DR, Lang PA, Maretzky T, Hamada K, Ohishi K, Maney SK et al. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS. Science 2012; 335: 229-232.
32. Lang PA, Shaabani N, Borkens S, Honke N, Scheu S, Booth S et al. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency. J Allergy Clin Immunol 2013; 131: 815-824.
33. Lang PA, Recher M, Honke N, Scheu S, Borkens S, Gailus N et al. Tissue macrophages suppress viral replication and prevent severe immunopathology in an interferon-I-dependent manner in mice. Hepatology 2010; 52: 25-32.
34. Lang PA, Xu HC, Grusdat M, McIlwain DR, Pandyra AA, Harris IS et al. Reactive oxygen species delay control of lymphocytic choriomeningitis virus. Cell Death Differ 2013; 20: 649-658.
35. Bachmann MF, Speiser DE, Ohashi PS. Functional management of an antiviral cytotoxic T-cell response. J Virol 1997; 71: 5764-5768.